This article is more than 5 years old. Information may no longer be current.
Sanofi, Google collaborate to streamline diabetes technology
Click Here to Manage Email Alerts
Sanofi and the life sciences team at Google will collaborate to develop new diabetes management technology that will streamline the health information typically stored on different diabetes devices, according to a press release from the two companies.
The companies will combine their respective expertise in science and technology to use data and miniaturized technology to provide patients with more tools to better self-manage their diabetes, improving on current methods to collect, analyze and understand multiple sources of diabetes information, including blood glucose, HbA1c, medication regimens and sensor devices.
"As a global leader in diabetes care, we have both an obligation and a commitment to provide integrated solutions for people living with diabetes," Olivier Brandicourt, MD, chief executive officer of Sanofi, said in a statement. "This initiative combines Sanofi's strength and knowledge in diabetes with Google's leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care."
"With new technologies emerging to provide a more continuous and real-time view of a patient's health, we can see the promise for more proactive and effective ways to control diabetes," Andy Conrad, CEO of the life sciences team at Google, said in a press release. "Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life."
The Joslin Diabetes Center will also partner with the collaboration. In a statement, John L. Brooks, III, president and CEO of Joslin Diabetes Center, said the initiative can improve the quality of life and reduce cost for people living with diabetes.
"We are experiencing a worldwide pandemic of diabetes, and it's very encouraging to see health care and technology innovators step up to the challenge of providing cutting edge tools and care-advancing technologies to help people with diabetes manage their disease, 24/7," Brookes said. "Technology, sensors, analytics and digital solutions will revolutionize how blood sugars are managed, which will deliver improved quality of life, lowering the risk of complications and reducing the costs and barriers associated with diabetes care. Ultimately, I truly hope we're able to turn the Joslin Diabetes Center into a museum."